Odds are it won't. Remember GC mentioning that he'

Odds are it won't. Remember GC mentioning that he'd talk about Lympro rev guidance and WE NEVER EVER GOT IT? I wonder why? Lympro might actually have to be renamed to LIMPro as it is becoming obvious that the company is having a hard time getting BP to use it. I hope that changes once those so called peer review journal articles come out.

My Agenda: To see Amarantus prosper so I can make a nice return on my investment.